JANET CUTTNER, M.D.
Ulcerative colitis is an inflammatory disease of unknown origin. Immune mechanisms are now considered important in the etiology of this disease (1-3). Recognized hematologic complications in this disorder include iron deficiency anemia related to bleeding, and Coombs' positive hemolytic anemia associated with the drug salicylazosulfapyridine (Azulfidine, Pharmacia Laboratories, Piscataway, New Jersey). Thrombocytosis and leukocytosis can occur in the active phase of the disease. We report six patients with a long-standing history of ulcerative colitis who developed acute leukemia; five cases of which were of a specific subtype, acute promyelocytic leukemia.
From 1974 through 1981, 227 patients newly diagnosed as having
Learn more about subscription options.
Register Now for a free account.
CUTTNER J. Increased Incidence of Acute Promyelocytic Leukemia in Patients with Ulcerative Colitis. Ann Intern Med. 1982;97:864–865. doi: 10.7326/0003-4819-97-6-864
Download citation file:
Published: Ann Intern Med. 1982;97(6):864-865.
Gastroenterology/Hepatology, Hematology/Oncology, Inflammatory Bowel Disease, Leukemia/Lymphoma.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only